Carmoterol - Mitsubishi Tanabe Pharma Corporation
Alternative Names: CHF 4226; TA 2005Latest Information Update: 24 Oct 2021
At a glance
- Originator Tanabe Seiyaku
- Class Amphetamines; Antiasthmatics; Bronchodilators; Hydroxyquinolines; Quinolones; Small molecules
- Mechanism of Action Beta 2 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Chronic obstructive pulmonary disease
Most Recent Events
- 19 May 2011 Discontinued - Phase-II for Chronic obstructive pulmonary disease in Europe (Inhalation)
- 19 May 2011 Discontinued - Phase-II for Chronic obstructive pulmonary disease in South Africa (Inhalation)
- 19 May 2011 Discontinued - Phase-II for Chronic obstructive pulmonary disease in USA (Inhalation)